Tested Applications
| Positive WB detected in | HEK-293 cells, HeLa cells, DU 145 cells, fetal human brain tissue, mouse kidney tissue |
Recommended dilution
| Application | Dilution |
|---|---|
| Western Blot (WB) | WB : 1:500-1:1000 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Product Information
20201-1-AP targets STEAP2 in WB, ELISA applications and shows reactivity with human, mouse samples.
| Tested Reactivity | human, mouse |
| Cited Reactivity | human, mouse |
| Host / Isotype | Rabbit / IgG |
| Class | Polyclonal |
| Type | Antibody |
| Immunogen |
Peptide Predict reactive species |
| Full Name | six transmembrane epithelial antigen of the prostate 2 |
| Calculated Molecular Weight | 56 kDa |
| Observed Molecular Weight | 48-52 kDa |
| GenBank Accession Number | NM_152999 |
| Gene Symbol | STEAP2 |
| Gene ID (NCBI) | 261729 |
| RRID | AB_10665556 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Antigen affinity purification |
| UNIPROT ID | Q8NFT2 |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Background Information
STEAP2, also named as PCANAP1 and STAMP1, belongs to the STEAP family. It is a metalloreductase that has the ability to reduce both Fe3+ to Fe2+ and Cu2+ to Cu1+. STEAP2 uses NAD+ as acceptor. The antibody is specific to STEAP2.
Protocols
| Product Specific Protocols | |
|---|---|
| WB protocol for STEAP2 antibody 20201-1-AP | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
What published studies show
The STEAP2 Polyclonal antibody (Cat# 20201-1-AP) has 5 citations. These appear in Cell Death & Disease, Molecular Cancer Research, Cancer Biology & Therapy, Journal of Cellular and Molecular Medicine, and Experimental Cell Research. The research fields span papillary thyroid cancer, prostate cancer, osteosarcoma, idiopathic pulmonary fibrosis, and STEAP2 intracellular trafficking. All citations used the antibody for Western blot (WB), with studies in human and mouse species.
| Species | Application | Title |
|---|---|---|
Cell Death Dis METTL3-mediated m6A modification of STEAP2 mRNA inhibits papillary thyroid cancer progress by blocking the Hedgehog signaling pathway and epithelial-to-mesenchymal transition.
| ||
Mol Cancer Res Exploring STEAP1 Expression in Prostate Cancer Cells in Response to Androgen Deprivation and in Small Extracellular Vesicles | ||
Cancer Biol Ther STEAP2 promotes osteosarcoma progression by inducing epithelial–mesenchymal transition via the PI3K/AKT/mTOR signaling pathway and is regulated by EFEMP2
| ||
J Cell Mol Med Unveiling the role of copper metabolism and STEAP2 in idiopathic pulmonary fibrosis molecular landscape
| ||
Exp Cell Res Membrane cholesterol modulates STEAP2 conformation during dynamic intracellular trafficking processes leading to broad subcellular distribution. |











